View in EDS

Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma.
Authors: Bal S; University of Alabama at Birmingham, Birmingham, Alabama, United States., Htut M; City of Hope, Duarte, California, United States., Nadeem O; Dana-Farber Cancer Institute, Boston, Massachusetts, United States., Anderson LD Jr; University of Texas Southwestern Medical Center, Dallas, Texas, United States., Gregory T; Colorado Blood Cancer Institute, Dever, Colorado, United States., Kocoglu M; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States., Rossi AC; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, United States., Martin TG; UCSF, San Francisco, California, United States., Egan DN; Swedish Cancer Institute, Seattle, Washington, United States., Costa LJ; University of Alabama at Birmingham, Vestavia Hills, Alabama, United States., Hu H; Bristol Myers Squibb, Princeton, New Jersey, United States., Chen J; Bristol Myers Squibb, Princeton, New Jersey, United States., Li S; Bristol Myers Squibb, Princeton, New Jersey, United States., Kelly LM; Bristol Myers Squibb, Princeton, New Jersey, United States., Sarkis N; Bristol Myers Squibb, Princeton, New Jersey, United States., Ziyad S; Bristol Myers Squibb, Princeton, New Jersey, United States., Jordahl KM; Bristol Myers Squibb, Princeton, New Jersey, United States., Kao WM; Bristol Myers Squibb, Brisbane, California, United States., Kaeding AJ; Bristol Myers Squibb, United States., Burgess MR; Bristol Myers Squibb, Princeton, New Jersey, United States., Berdeja JG; Greco-Hainsworth Tennessee Oncology Centers for Research, nashville, Tennessee, United States.
Source: Blood [Blood] 2026 Jun 02. Date of Electronic Publication: 2026 Jun 02.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42233419
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bal+S%22">Bal S</searchLink>; University of Alabama at Birmingham, Birmingham, Alabama, United States.<br /><searchLink fieldCode="AU" term="%22Htut+M%22">Htut M</searchLink>; City of Hope, Duarte, California, United States.<br /><searchLink fieldCode="AU" term="%22Nadeem+O%22">Nadeem O</searchLink>; Dana-Farber Cancer Institute, Boston, Massachusetts, United States.<br /><searchLink fieldCode="AU" term="%22Anderson+LD+Jr%22">Anderson LD Jr</searchLink>; University of Texas Southwestern Medical Center, Dallas, Texas, United States.<br /><searchLink fieldCode="AU" term="%22Gregory+T%22">Gregory T</searchLink>; Colorado Blood Cancer Institute, Dever, Colorado, United States.<br /><searchLink fieldCode="AU" term="%22Kocoglu+M%22">Kocoglu M</searchLink>; University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, Maryland, United States.<br /><searchLink fieldCode="AU" term="%22Rossi+AC%22">Rossi AC</searchLink>; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, United States.<br /><searchLink fieldCode="AU" term="%22Martin+TG%22">Martin TG</searchLink>; UCSF, San Francisco, California, United States.<br /><searchLink fieldCode="AU" term="%22Egan+DN%22">Egan DN</searchLink>; Swedish Cancer Institute, Seattle, Washington, United States.<br /><searchLink fieldCode="AU" term="%22Costa+LJ%22">Costa LJ</searchLink>; University of Alabama at Birmingham, Vestavia Hills, Alabama, United States.<br /><searchLink fieldCode="AU" term="%22Hu+H%22">Hu H</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, United States.<br /><searchLink fieldCode="AU" term="%22Chen+J%22">Chen J</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, United States.<br /><searchLink fieldCode="AU" term="%22Li+S%22">Li S</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, United States.<br /><searchLink fieldCode="AU" term="%22Kelly+LM%22">Kelly LM</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, United States.<br /><searchLink fieldCode="AU" term="%22Sarkis+N%22">Sarkis N</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, United States.<br /><searchLink fieldCode="AU" term="%22Ziyad+S%22">Ziyad S</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, United States.<br /><searchLink fieldCode="AU" term="%22Jordahl+KM%22">Jordahl KM</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, United States.<br /><searchLink fieldCode="AU" term="%22Kao+WM%22">Kao WM</searchLink>; Bristol Myers Squibb, Brisbane, California, United States.<br /><searchLink fieldCode="AU" term="%22Kaeding+AJ%22">Kaeding AJ</searchLink>; Bristol Myers Squibb, United States.<br /><searchLink fieldCode="AU" term="%22Burgess+MR%22">Burgess MR</searchLink>; Bristol Myers Squibb, Princeton, New Jersey, United States.<br /><searchLink fieldCode="AU" term="%22Berdeja+JG%22">Berdeja JG</searchLink>; Greco-Hainsworth Tennessee Oncology Centers for Research, nashville, Tennessee, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%227603509%22">Blood</searchLink> [Blood] 2026 Jun 02. <i>Date of Electronic Publication: </i>2026 Jun 02.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%22">Elsevier </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>7603509 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1528-0020 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200064971%22">00064971 </searchLink><i>NLM ISO Abbreviation: </i>Blood <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42233419
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/blood.2025030750
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bal S
      – PersonEntity:
          Name:
            NameFull: Htut M
      – PersonEntity:
          Name:
            NameFull: Nadeem O
      – PersonEntity:
          Name:
            NameFull: Anderson LD Jr
      – PersonEntity:
          Name:
            NameFull: Gregory T
      – PersonEntity:
          Name:
            NameFull: Kocoglu M
      – PersonEntity:
          Name:
            NameFull: Rossi AC
      – PersonEntity:
          Name:
            NameFull: Martin TG
      – PersonEntity:
          Name:
            NameFull: Egan DN
      – PersonEntity:
          Name:
            NameFull: Costa LJ
      – PersonEntity:
          Name:
            NameFull: Hu H
      – PersonEntity:
          Name:
            NameFull: Chen J
      – PersonEntity:
          Name:
            NameFull: Li S
      – PersonEntity:
          Name:
            NameFull: Kelly LM
      – PersonEntity:
          Name:
            NameFull: Sarkis N
      – PersonEntity:
          Name:
            NameFull: Ziyad S
      – PersonEntity:
          Name:
            NameFull: Jordahl KM
      – PersonEntity:
          Name:
            NameFull: Kao WM
      – PersonEntity:
          Name:
            NameFull: Kaeding AJ
      – PersonEntity:
          Name:
            NameFull: Burgess MR
      – PersonEntity:
          Name:
            NameFull: Berdeja JG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 02
              M: 06
              Text: 2026 Jun 02
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1528-0020
          Titles:
            – TitleFull: Blood
              Type: main
ResultId 1